In addition, we conducted an exploratory analysis of early pregnancy hormones and breast cancer risk by tumor androgen receptor (AR) status; to our knowledge, this is the first investigation of early pregnancy hormones and breast cancer risk by AR status. The gene discussed is AR; the disease is breast carcinoma.